Clinical Trial Update: This is a Phase II, Open-label, Multicentre Study of Zanubrutinib-containing Regimens in Patients With Newly Diagnosed Mantle Cell Lymphoma [Phase 2]

View source ↗

Summary

This is a Phase II, open-label multicenter study evaluating regimens containing zanubrutinib in newly diagnosed mantle cell lymphoma. The trial status is not ye…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Zanubrutinib (zanubrutinib)

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Lymphoma, Mantle-Cell, Lymphoma, Non-Hodgkin | Phase 2 | Status: NOT_YET_RECRUITING